Three trials presented at ASCO GI 2025 will change practice and improve the treatment of colorectal cancer, according to experts.

Researchers found that higher maternal BMI in early pregnancy and before delivery were associated with an increased risk of ALL in female offspring, but there were no such associations for male ...

Patients treated with platinum-based agents and taxanes had the highest prevalence of chronic painful chemotherapy-induced peripheral neuropathy, researchers found.

Artificial intelligence systems require consistent monitoring and staffing to put in place and to keep them working well.

In a survey, less than half of cancer patients and their family members said they were willing to participate in a clinical trial, and about a third of respondents said they had a positive perception ...

The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

Adding atezolizumab to adjuvant chemotherapy does not improve outcomes in patients with stage II-III TNBC, phase 3 data suggest.

Tislelizumab plus low-dose nab-paclitaxel “demonstrated enduring efficacy while maintaining a manageable safety profile,” according to researchers.

The improvement in the well-being of fellows over the past decade likely stems from intentional changes to training programs,” researchers wrote.

Some patients who had disease progression after stopping larotrectinib achieved a response after resuming larotrectinib.

Provider prioritization of relationship-building alongside explanations could foster trust and facilitate open information exchange, supporting informed decisions,” researchers wrote.

The cost of caring for a Medicare patient far outpaces the reimbursement that physicians receive for seeing them,” said Congressman Greg Murphy, MD (R-NC).